Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PABPC1 | P11940 | 1/20 | 0.40 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.40 |
| ▸ | TYK2 | P29597 | 4/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | AGER | Q15109 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | JAK1 | P23458 | 3/20 | 0.36 |
| ▸ | JAK2 | O60674 | 2/20 | 0.36 |
| ▸ | JAK3 | P52333 | 1/20 | 0.36 |
| ▸ | KIT | P10721 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | ACLY | P53396 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL18784167 | 0.97 | PABPC1 (0.40) | PABPC1EIF4HTYK2L3MBTL1KDM4E | |
| SCHEMBL18784146 | 0.97 | PABPC1 (0.40) | PABPC1EIF4HTYK2L3MBTL1KDM4E | |
| Lithium Ion SCHEMBL18784153 | 0.83 | COMT (0.48) | L3MBTL1KDM4EMAPTALDH1A1CYP3A4 | |
| SCHEMBL1252476 | 0.82 | KDM4E (0.53) | PABPC1EIF4HL3MBTL1KDM4EMAPT | |
| SCHEMBL30547366 | 0.81 | L3MBTL1 (0.55) | PABPC1EIF4HL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL5700122 | 0.81 | L3MBTL1 (0.55) | PABPC1EIF4HL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL3914430 | 0.81 | MKNK1 (0.41) | PABPC1EIF4HTYK2L3MBTL1KDM4E | |
| SCHEMBL18784138 | 0.80 | COMT (0.48) | L3MBTL1KDM4EMAPTALDH1A1CYP3A4 | |
| Potassium Ion SCHEMBL18784160 | 0.80 | COMT (0.48) | L3MBTL1KDM4EMAPTALDH1A1CYP3A4 | |
| Lithium Ion SCHEMBL18784188 | 0.80 | TSHR (0.42) | L3MBTL1KDM4EMAPTALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3162795-B1 | METHOD FOR MANUFACTURING 3-(ALKYL SULFONYL)PYRIDINE-2-CARBOXYLIC ACID | SUMITOMO CHEMICAL CO (JP) | 2019-07-31 | — | — | EP | disclosed |
| US-9815786-B2 | Method for manufacturing 3-(alkylsulfonyl)pyridine-2-carboxylic acid | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-11-14 | — | — | US | disclosed |
| US-20170129859-A1 | METHOD FOR MANUFACTURING 3-(ALKYLSULFONYL)PYRIDINE-2-CARBOXYLIC ACID | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-05-11 | — | — | US | disclosed |
| EP-3162795-A1 | METHOD FOR MANUFACTURING 3-(ALKYL SULFONYL)PYRIDINE-2-CARBOXYLIC ACID | Sumitomo Chemical Company, Limited (JP) | 2017-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170129859-A1 | METHOD FOR MANUFACTURING 3-(ALKYLSULFONYL)PYRIDINE-2-CARBOXYLIC ACID | STS, SRM, CERS2 | PABPC1 3554/4885EIF4H 1947/4885TYK2 252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.